Help
Subscribe


Submit Videos to GastroHep Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Polypectomy rate as a surrogate for adenoma detection rate

Polypectomy rate as a surrogate for adenoma detection rate varies by colon segment, gender, and endoscopist, reports the latest issue of the Clinical Gastroenterology & Hepatology.

News image

The adenoma detection rate is an important measure of the quality of colonoscopy.

It is associated with interval colorectal cancer and varies among sexes and locations.

Recommended indicators of competence for colonoscopy include minimal adenoma detection rate >25% for average-risk men and >15% for women.

These adenoma detection rates are rigorous, so polypectomy detection rate has been suggested as a surrogate.

Colonoscopy is less effective in the proximal colon, where interval cancers are more likely to occur.

Dr Madhusudhan Sanaka and colleagues compared adenoma detection rates and polypectomy detection rates in different segments of colon and between sexes.

The mean overall polypectomy detection rate was 42%
Clinical Gastroenterology & Hepatology

The research team performed a cross-sectional review of findings from 2167 screening colonoscopies performed by 65 endoscopists on average-risk outpatients at the Cleveland Clinic, 2008–2009.

The team reviewed colonoscopy and pathology reports of randomly selected procedures.

The researchers calculated polypectomy detection rates, adenoma detection rates, and correlation between polypectomy and adenoma detection rate for each colon segment and sex.

The team found that the mean overall polypectomy detection rate was 42%, and adenoma detection rate was 25%.

The team noted that the correlation between overall adenoma detection rate and polypectomy detection rate was stron.

Polypectomy detection rate of 40% in men and 30% in women correlated with the established minimum benchmark adenoma detection rates of 25% and 15% for men and women, respectively.

Polypectomy detection rate was more strongly correlated with adenoma detection rate in the proximal colon than the distal colon.

The researcher's correlation was stronger in men than in women, as well as in the entire colon, the proximal colon, and the distal colon.

The advanced adenoma detection rate was 4% and did not correlate with polypectomy detection rate.

Dr Sanaka's team concludes, "On the basis of a review of findings from screening colonoscopies, overall polypectomy detection rate correlates with adenoma detection rate for the entire colon, but polypectomy detection rate and adenoma detection rate correlate most strongly for the proximal colon, where many adenomas can be missed and interval cancers develop."

"The correlation between polypectomy detection rate and adenoma detection rate is weaker for women than men and for distal colon."

"If polypectomy detection rate is used as a surrogate for adenoma detection rate, colon location and patient sex should be considered."

Clin Gastroenterol Hepatol 2014: 12(7): 1137–1142
30 June 2014

Go to top of page Email this page Email this page to a colleague

 29 March 2015

Advanced search
 27 March 2015 
Screening for fecal incontinence
 27 March 2015 
Deep remission in Crohn's disease
 27 March 2015 
Sexual functioning in IBD
 26 March 2015 
Antimicrobial therapy in cirrhosis with spontaneous bacterial peritonitis
 26 March 2015 
Metformin as a chemopreventive agent for Barrett's
 26 March 2015 
Survival of untreated hepatocellular carcinoma
 25 March 2015 
Genetics and Crohn's disease
 25 March 2015 
Mortality in Barrett’s–related T1 esophageal adenocarcinoma
 25 March 2015 
Cytomegalovirus and IBD
 24 March 2015 
Prevention of colorectal cancer after screening
 24 March 2015 
Functional GI disorders and body mass index
 24 March 2015 
Quality of life in children with fecal incontinence
 23 March 2015 
Fibrosis in NAFLD vs NASH
 23 March 2015 
The unmasking of Whipple's disease
 23 March 2015 
Predicting the quality of colon cancer care
 20 March 2015 
Interventions for eosinophilic esophagitis
 20 March 2015 
Colorectal cancer risk and genetic variants
 20 March 2015 
Screening for Barrett's esophagus
 19 March 2015 
Hypnotherapy for IBS
 19 March 2015 
Poor mental and physical health in HCV
 19 March 2015 
Dedicated care for diverticular disease
 18 March 2015 
Practice guidelines for colorectal polyps
 18 March 2015 
Out-of-hours endoscopy for upper GI bleeding
 18 March 2015 
H. pylori eradication and lipids
 17 March 2015 
H. pylori test-and-treat program and gastric cancer
 17 March 2015 
Adalimumab in Crohn’s disease
 17 March 2015 

Low-dose PPIs and GI bleeding in patients receiving aspirin

 16 March 2015 
Microscopic colitis
 16 March 2015 
Cholestasis of pregnancy with HCV
 16 March 2015 
Hybrid therapy for H. pylori
 13 March 2015 
Medicare patients and payments to gastroenterologists
 13 March 2015 
Appendectomy in ulcerative colitis
 13 March 2015 

Racial disparities in gluten-sensitive problems

 12 March 2015 
Predicting IBD in IBS patients
 12 March 2015 
Patient knowledge of IBS
 12 March 2015 
Nonceliac gluten sensitivity
 11 March 2015 

Prediction of malignant bile duct obstruction

 11 March 2015 
NAFLD–related hepatocellular carcinoma
 11 March 2015 
Assessment of eosinophilic esophagitis
 10 March 2015 
Poor disease course in pediatric ulcerative colitis
 10 March 2015 
Risk for gastroesophageal reflux symptoms
 10 March 2015 
Outcomes in Crohn's therapy
 09 March 2015 
Fibre usage in ulcerative colitis in remission
 09 March 2015 
Risk of C. difficile upon hospital admission
 09 March 2015 
Gastric Cancer detection during GI endosocopy
 06 March 2015 
Steroid therapy for eosinophilic esophagitis
 06 March 2015 
Second anti-TNF in IBD
 06 March 2015 
Efficacy of Hep E vaccine
 05 March 2015 
EPHXI polymorphism and esophageal cancer risk
 05 March 2015 
Infliximab and immunosuppressant therapy in ulcerative colitis
 05 March 2015 
Neuroendocrine carcinoma of the colon and rectum
 04 March 2015 
Multidisciplinary management of rectal cancer
 04 March 2015 
Management of IBD
 04 March 2015 
Progression of Barrett's
 03 March 2015 
EPHX1 polymorphism and esophageal cancer risk
 03 March 2015 
GI bleeding in chronic kidney disease patients on aspirin
 03 March 2015 
Risk of anastomotic leak after colectomy
 02 March 2015 
Genes and early diagnosis of IBD
 02 March 2015 
Assessment of GERD
 02 March 2015 
Liver disease in patients awaiting liver transplant

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2015 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us